Physician profile
Marius Commodore
NPI 1568660652
$815.74
in general payments reported to CMS, 2019-2025
14 companies · $643 in 2025
The $643 reported for 2025 was more than what 78% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $15.66 · 2024: $158 · 2025: $643.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $816.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $815.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $281.54 | 2024-2025 | Invega |
| Theratechnologies INC. | $79.28 | 2025 | Trogarzo, Egrifta |
| Alkermes, INC. | $78.94 | 2023-2025 | Lybalvi, Vivitrol |
| Indivior INC. | $66.45 | 2024-2025 | Sublocade, Perseris |
| Braeburn INC. | $63.82 | 2024-2025 | Brixadi |
| Exact Sciences Corporation | $60.85 | 2025 | The Cologuard Plus Collection Kit |
| Viiv Healthcare Company | $46.24 | 2025 | Apretude |
| Gilead Sciences, INC. | $32.90 | 2024-2025 | Biktarvy |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $22.45 | 2025 | |
| Genzyme Corporation | $18.11 | 2024 | |
| Lilly USA, LLC | $17.59 | 2025 | Zepbound, Mounjaro |
| Otsuka America Pharmaceutical, INC. | $16.81 | 2025 | Abilify Maintena |
| Hologic Sales and Service, LLC | $15.61 | 2025 | Aptima |
| E.R. Squibb & Sons, L.L.C. | $15.15 | 2025 | Cobenfy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marius Commodore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.